Titre : Hyperthermie provoquée

Hyperthermie provoquée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Hyperphosphatemia
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hyperthermie provoquée : Questions médicales les plus fréquentes", "headline": "Hyperthermie provoquée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hyperthermie provoquée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-20", "dateModified": "2025-03-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hyperthermie provoquée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Thérapeutique", "url": "https://questionsmedicales.fr/mesh/D013812", "about": { "@type": "MedicalCondition", "name": "Thérapeutique", "code": { "@type": "MedicalCode", "code": "D013812", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Psammothérapie", "alternateName": "Ammotherapy", "url": "https://questionsmedicales.fr/mesh/D000646", "about": { "@type": "MedicalCondition", "name": "Psammothérapie", "code": { "@type": "MedicalCode", "code": "D000646", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.020" } } }, { "@type": "MedicalWebPage", "name": "Diathermie", "alternateName": "Diathermy", "url": "https://questionsmedicales.fr/mesh/D003972", "about": { "@type": "MedicalCondition", "name": "Diathermie", "code": { "@type": "MedicalCode", "code": "D003972", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.280" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ultrasonothérapie", "alternateName": "Ultrasonic Therapy", "url": "https://questionsmedicales.fr/mesh/D014464", "about": { "@type": "MedicalCondition", "name": "Ultrasonothérapie", "code": { "@type": "MedicalCode", "code": "D014464", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.280.945" } } } ] }, { "@type": "MedicalWebPage", "name": "Chimiothérapie hyperthermique intrapéritonéale", "alternateName": "Hyperthermic Intraperitoneal Chemotherapy", "url": "https://questionsmedicales.fr/mesh/D000084262", "about": { "@type": "MedicalCondition", "name": "Chimiothérapie hyperthermique intrapéritonéale", "code": { "@type": "MedicalCode", "code": "D000084262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.370" } } }, { "@type": "MedicalWebPage", "name": "Bain de vapeur", "alternateName": "Steam Bath", "url": "https://questionsmedicales.fr/mesh/D029002", "about": { "@type": "MedicalCondition", "name": "Bain de vapeur", "code": { "@type": "MedicalCode", "code": "D029002", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.640" } } } ], "about": { "@type": "MedicalCondition", "name": "Hyperthermie provoquée", "alternateName": "Hyperthermia, Induced", "code": { "@type": "MedicalCode", "code": "D006979", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohammad-Amin Abdollahifar", "url": "https://questionsmedicales.fr/author/Mohammad-Amin%20Abdollahifar", "affiliation": { "@type": "Organization", "name": "Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: abdollahima@sbmu.ac.ir." } }, { "@type": "Person", "name": "Abbas Aliaghaei", "url": "https://questionsmedicales.fr/author/Abbas%20Aliaghaei", "affiliation": { "@type": "Organization", "name": "Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Jon E Sprague", "url": "https://questionsmedicales.fr/author/Jon%20E%20Sprague", "affiliation": { "@type": "Organization", "name": "The Ohio Attorney General's Center for the Future of Forensic Science, USA. Electronic address: jesprag@bgsu.edu." } }, { "@type": "Person", "name": "Amir Raoofi", "url": "https://questionsmedicales.fr/author/Amir%20Raoofi", "affiliation": { "@type": "Organization", "name": "Leishmaniasis Research Center, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran." } }, { "@type": "Person", "name": "Shabnam Abdi", "url": "https://questionsmedicales.fr/author/Shabnam%20Abdi", "affiliation": { "@type": "Organization", "name": "Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Nephron index rather than serum FGF 23 predicts endothelial dysfunction in early but not advanced chronic kidney disease patients.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37043155", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-023-03589-y" } }, { "@type": "ScholarlyArticle", "name": "Tumor lysis syndrome promotes cancer chemoresistance and relapse through AMPK inhibition.", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36527883", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.intimp.2022.109568" } }, { "@type": "ScholarlyArticle", "name": "[Hyperphosphatemic pseudotumoral calcinosis due to FGF23 mutation with secondary amyloidosis].", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36073335", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } }, { "@type": "ScholarlyArticle", "name": "A real-world analysis of the influence of age on maintenance hemodialysis patients: managing serum phosphorus with sucroferric oxyhydroxide as part of routine clinical care.", "datePublished": "2022-08-11", "url": "https://questionsmedicales.fr/article/35953565", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-022-03327-w" } }, { "@type": "ScholarlyArticle", "name": "Electrolytes disturbances in cancer patients.", "datePublished": "2022-07-18", "url": "https://questionsmedicales.fr/article/35894276", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MNH.0000000000000819" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013812" }, { "@type": "ListItem", "position": 3, "name": "Hyperthermie provoquée", "item": "https://questionsmedicales.fr/mesh/D006979" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hyperthermie provoquée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hyperthermie provoquée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hyperthermie provoquée", "description": "Comment diagnostiquer l'hyperthermie provoquée ?\nQuels tests sont utilisés pour confirmer l'hyperthermie ?\nQuels signes cliniques indiquent une hyperthermie ?\nL'hyperthermie est-elle toujours dangereuse ?\nComment différencier l'hyperthermie de la fièvre ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hyperthermie provoquée", "description": "Quels sont les symptômes de l'hyperthermie provoquée ?\nL'hyperthermie provoquée cause-t-elle des douleurs ?\nPeut-on avoir des troubles de la conscience ?\nY a-t-il des signes cutanés associés ?\nL'hyperthermie provoquée affecte-t-elle la respiration ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hyperthermie provoquée", "description": "Comment prévenir l'hyperthermie provoquée ?\nLes vêtements influencent-ils l'hyperthermie ?\nFaut-il surveiller la température corporelle ?\nLes pauses sont-elles importantes ?\nL'alimentation joue-t-elle un rôle ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hyperthermie provoquée", "description": "Comment traiter l'hyperthermie provoquée ?\nDes médicaments sont-ils nécessaires ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il consulter un médecin ?\nLe repos est-il recommandé ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hyperthermie provoquée", "description": "Quelles complications peuvent survenir ?\nL'hyperthermie peut-elle être mortelle ?\nQuels organes sont les plus affectés ?\nDes séquelles peuvent-elles persister ?\nComment éviter les complications graves ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hyperthermie provoquée", "description": "Qui est le plus à risque d'hyperthermie ?\nL'exercice augmente-t-il le risque ?\nLes médicaments influencent-ils le risque ?\nL'humidité joue-t-elle un rôle ?\nLe surpoids est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hyperthermie provoquée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique et la mesure de la température corporelle." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer l'hyperthermie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des évaluations physiologiques peuvent être réalisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une hyperthermie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent une température élevée, des frissons et une confusion mentale." } }, { "@type": "Question", "name": "L'hyperthermie est-elle toujours dangereuse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, elle peut être contrôlée, mais nécessite une surveillance." } }, { "@type": "Question", "name": "Comment différencier l'hyperthermie de la fièvre ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'hyperthermie est causée par des facteurs externes, alors que la fièvre est une réponse immunitaire." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hyperthermie provoquée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges, des maux de tête et une confusion." } }, { "@type": "Question", "name": "L'hyperthermie provoquée cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des douleurs musculaires et des crampes." } }, { "@type": "Question", "name": "Peut-on avoir des troubles de la conscience ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la conscience peuvent survenir en cas d'hyperthermie sévère." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des rougeurs ou des éruptions cutanées peuvent apparaître en cas d'hyperthermie." } }, { "@type": "Question", "name": "L'hyperthermie provoquée affecte-t-elle la respiration ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner une respiration rapide et superficielle." } }, { "@type": "Question", "name": "Comment prévenir l'hyperthermie provoquée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les environnements chauds et hydratez-vous régulièrement lors d'activités physiques." } }, { "@type": "Question", "name": "Les vêtements influencent-ils l'hyperthermie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter des vêtements légers et respirants aide à prévenir l'hyperthermie." } }, { "@type": "Question", "name": "Faut-il surveiller la température corporelle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, surveiller la température est essentiel lors d'activités à risque." } }, { "@type": "Question", "name": "Les pauses sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, prendre des pauses régulières lors d'activités physiques intenses est crucial." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée aide à maintenir une bonne régulation thermique." } }, { "@type": "Question", "name": "Comment traiter l'hyperthermie provoquée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut le refroidissement du corps et l'hydratation adéquate." } }, { "@type": "Question", "name": "Des médicaments sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être administrés pour soulager les symptômes associés." } }, { "@type": "Question", "name": "Quelle est l'importance de l'hydratation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation est cruciale pour prévenir des complications graves liées à l'hyperthermie." } }, { "@type": "Question", "name": "Quand faut-il consulter un médecin ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si les symptômes persistent ou s'aggravent malgré le traitement." } }, { "@type": "Question", "name": "Le repos est-il recommandé ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le repos est essentiel pour permettre au corps de récupérer." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des coups de chaleur, des défaillances organiques et des convulsions." } }, { "@type": "Question", "name": "L'hyperthermie peut-elle être mortelle ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hyperthermie sévère non traitée peut entraîner la mort." } }, { "@type": "Question", "name": "Quels organes sont les plus affectés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le cerveau, le cœur et les reins sont particulièrement vulnérables à l'hyperthermie." } }, { "@type": "Question", "name": "Des séquelles peuvent-elles persister ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles neurologiques peuvent persister après une hyperthermie sévère." } }, { "@type": "Question", "name": "Comment éviter les complications graves ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement rapide et approprié est essentiel pour éviter les complications graves." } }, { "@type": "Question", "name": "Qui est le plus à risque d'hyperthermie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées, les enfants et celles avec des maladies chroniques sont plus à risque." } }, { "@type": "Question", "name": "L'exercice augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice intense dans des environnements chauds augmente le risque d'hyperthermie." } }, { "@type": "Question", "name": "Les médicaments influencent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent altérer la régulation thermique et augmenter le risque." } }, { "@type": "Question", "name": "L'humidité joue-t-elle un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une humidité élevée augmente le risque d'hyperthermie en réduisant l'évaporation de la sueur." } }, { "@type": "Question", "name": "Le surpoids est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le surpoids peut augmenter le risque d'hyperthermie en réduisant l'efficacité de la thermorégulation." } } ] } ] }

Sources (91 au total)

Nephron index rather than serum FGF 23 predicts endothelial dysfunction in early but not advanced chronic kidney disease patients.

Endothelial dysfunction is the primary step for the development of CKD-related cardiovascular disease. Early prediction and management can influence patient survival. Serum testing of FGF 23 hormone a... A cross-sectional comparative analysis between thirty CKD stage 3 patients and sixty stage 4-5 CKD patients was conducted. All patients were tested for markers of mineral bone disorders including seru... In univariate and multivariate regression analyses, the nephron index was the only predictor of endothelial dysfunction in individuals with stage 3 CKD (r = 0.74, P 0.01). This was not applied to stag... Nephron index calculation showed better correlation with endothelial dysfunction than using any of its determinants alone in early stages of CKD when FGF 23 levels are just beginning to rise. In advan...

A real-world analysis of the influence of age on maintenance hemodialysis patients: managing serum phosphorus with sucroferric oxyhydroxide as part of routine clinical care.

Despite the growing number of elderly hemodialysis patients, the influence of age on nutritional parameters, serum phosphorus (sP), and use of phosphate-binder (PB) medications has not been well chara... We retrospectively analyzed de-identified data from 2017 adult, in-center hemodialysis patients who switched from another PB to SO monotherapy as part of routine clinical care. Changes in baseline PB ... At baseline, older patients had lower mean sP, serum albumin, and pre-dialysis weights compared with younger patients. Prescription of SO was associated with a 62% increase in the proportion of patien... Older patients had worse nutritional parameters, lower pill burden, and lower sP at baseline versus younger counterparts. Prescription of SO was associated with improved sP control and reduced pill bu...

Electrolytes disturbances in cancer patients.

Hypernatremia, hyperphosphatemia, hypocalcaemia, hyperkalaemia and hypermagnesemia are electrolytes disturbances that can arise in cancer patients in relation to unique causes that are related to the ... There have been many cancer drugs approved in the field of oncology over the past several years and a subset of these drugs have been associated with electrolytes disturbances. This includes, for exam... This article provides an updated review of certain electrolytes disturbance in cancer patients and allows clinicians to have a greater awareness and knowledge of these electrolyte abnormalities in eff...

The effect of magnesium sulfate on maternal serum electrolytes and parathyroid hormone in pre-eclampsia.

To evaluate possible interactions of magnesium sulfate-the drug of choice in the management of pre-eclampsia/eclampsia-in response to a few case reports that revealed maternal electrolyte disturbances... Prospectively, women with pre-eclampsia were given 4 g of intravenous magnesium sulfate followed by a 2 g/h infusion up to 24 h after delivery. Sequential blood samples were drawn from each patient an... A total of 30 pregnant women with pre-eclampsia were evaluated. They were aged between 20 and 41 years with median gestational age of 37.6 (interquartile range 35.4-38.9) weeks. Only five patients rea... Our study implies that magnesium sulfate could cause hypermagnesemia-induced hypocalcemia in women with pre-eclampsia, independent from parathyroid hormone. The negative correlations between calcium a...

Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney disease.

In patients with chronic kidney disease (CKD), hyperphosphatemia is associated with several adverse outcomes, including bone fragility and progression of kidney and cardiovascular disease. However, th... Adequate phosphate control is one of the goals of treatment for CKD-mineral and bone disorder. However, ongoing studies are challenging the benefits of phosphate-lowering treatment. Nevertheless, the ... Future studies could confirm the benefits of phosphate control. Greater understanding of the complex distribution of phosphate among the body compartments will help us define a better therapeutic stra...